Resignation of Nominated Adviser and Broker Update

By

Regulatory News | 23 Nov, 2018

Updated : 11:25

RNS Number : 3582I
Arricano Real Estate PLC
23 November 2018
 

23 November 2018

Arricano Real Estate plc

("Arricano" or the "Company")

Resignation of Nominated Adviser and Broker Update

Arricano (AIM: ARO) announces that, further to the announcement on 9 November 2018, Smith & Williamson Corporate Finance Limited, the Company's nominated adviser and broker, has extended the effective termination date under its nominated adviser and broker agreement to 30 November 2018 ("Effective Date") whilst the Company progresses discussions with a new nominated adviser firm.

 

The Company remains in advanced discussions with an alternative nominated adviser firm and expects to appoint such firm prior to the Effective Date. Pursuant to AIM Rule 1, in the event that a replacement nominated adviser is not appointed by the Company by the Effective Date, trading in the Company's ordinary shares will be suspended and in case no replacement nominated adviser is appointed by the Company within one month thereafter, trading in the Company's ordinary shares will be cancelled.

 

A further announcement on the appointment of a new nominated adviser will be made in due course.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 956/2014.

 

 

For further information please contact:

 

CEO:

Arricano Real Estate plc

Mykhailo Merkulov

 

 

Tel: +380 44 569 6708

Financial PR:

Novella Communications Limited

Tim Robertson/Toby Andrews

 

 

Tel: +44 (0)20 3151 7008

Nominated Adviser and Broker:

Smith & Williamson Corporate Finance Limited

Azhic Basirov

 

 

Tel: +44 (0)20 7131 4000

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPBJBBTMBTTBTP

Last news